← Back to Clinical Trials
Recruiting NCT06385834

NCT06385834 The Effect of Morning vs Evening Aerobic Exercise Training on Cardiac Remodeling and Function Improvement in Patients After ST Elevation Myocardial Infarction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06385834
Status Recruiting
Phase
Sponsor RenJi Hospital
Condition ST-segment Elevation Myocardial Infarction (STEMI)
Study Type INTERVENTIONAL
Enrollment 201 participants
Start Date 2024-04-30
Primary Completion 2028-04-30

Eligibility & Interventions

Sex All sexes
Min Age 17 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
Morning aerobic exerciseEvening aerobic exercise

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 201 participants in total. It began in 2024-04-30 with a primary completion date of 2028-04-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of the study was to intervene in the Aerobic exercise time of patients with STEMI and to explore the optimal exercise time for STEMI patients

Eligibility Criteria

Inclusion Criteria: * Between 18 and 75-years-old; * Typical symptoms of acute myocardial infarction within 24 hours, with ST segment elevation of ≥1mm in two consecutive leads on electrocardiogram * After receiving complete revascularization treatment * Cardiac function grading I to II without any other serious complications * Left ventricular ejection fraction \>30% * Compliant with the guidelines of the American College of Cardiology/American Heart Association for participating in cardiac rehabilitation standards * Signed written informed consent. Exclusion Criteria: * Patients with unstable angina * severe symptomatic congestive heart failure detectable myocardial ischemia * valvular disease requiring surgery * severe ventricular arrhythmias * severe concomitant life-threatening diseases such as cancer, and rheumatoid disease * osteoarticular diseases that may affect the exercise process

Contact & Investigator

Central Contact

Jun PU, MD

✉ pujun310@hotmail.com

📞 13817577592

Frequently Asked Questions

Who can join the NCT06385834 clinical trial?

This trial is open to participants of all sexes, aged 17 Years or older, up to 75 Years, studying ST-segment Elevation Myocardial Infarction (STEMI). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06385834 currently recruiting?

Yes, NCT06385834 is actively recruiting participants. Contact the research team at pujun310@hotmail.com for enrollment information.

Where is the NCT06385834 trial being conducted?

This trial is being conducted at Shanghai, China.

Who is sponsoring the NCT06385834 clinical trial?

NCT06385834 is sponsored by RenJi Hospital. The trial plans to enroll 201 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology